Metformin × all-cause mortality

SynthesisFrontiers in endocrinology2020

Metformin Use and Risk of All-Cause Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease-A Systematic Review and Meta-Analysis.

Yao Hu et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 303,540 people · 2020

Not counted

Reduced deaths

−29%−39% to −16%

Bigger than 8 in 10 for all-cause mortality

As reported

RR 0.71, 95% CI 0.61–0.84 · the paper's word: All-cause mortality

One number in the abstract

the abstract, start to end

risks of all-cause mortality (Pooled RRs 0.71, 95%CI 0.61 to 0.84; I

← favours treatmentfavours comparator →
could be chance
All-cause mortality
RR 0.710.61–0.84
MetforminAll-cause mortality
1 / 3

23 papers cite it

2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33117278